Steve Eppler
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 3
-
- Melanoma and MAPK Pathways 5
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Jianfeng Lü (4 shared papers)René Bruno (3 shared papers)Bert L. Lum (2 shared papers)Jacques Gaudreault (2 shared papers)William Novotny (1 shared paper)Ashok Rakhit (4 shared papers)Marta Hamilton (3 shared papers)B. Lum (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Cancer Research (3 papers)Clinical Pharmacology & Therapeutics (2 papers)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesSwitzerlandNew Zealand
In The Last Decade
Steve Eppler
19 papers receiving 909 citations
Peers
Comparison fields: 5 of 78
- Ophthalmology 129
- Oncology 307
- Radiology, Nuclear Medicine and Imaging 167
- Genetics 74
- Hepatology 51
Countries citing papers authored by Steve Eppler
This map shows the geographic impact of Steve Eppler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Eppler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Eppler more than expected).
Fields of papers citing papers by Steve Eppler
This network shows the impact of papers produced by Steve Eppler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Eppler. The network helps show where Steve Eppler may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Eppler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 280 | |
| 2 | 2006 | 191 | |
| 3 | 2013 | 164 | |
| 4 | 2006 | 83 | |
| 5 | 2014 | 56 | |
| 6 | 2010 | 42 | |
| 7 | 2013 | 36 | |
| 8 | 2016 | 31 | |
| 9 | 2018 | 17 | |
| 10 | 2011 | 11 | |
| 11 | 2013 | 9 | |
| 12 | 2011 | 8 | |
| 13 | 2013 | 8 | |
| 14 | 2014 | 8 | |
| 15 | 2005 | 5 | |
| 16 | 2005 | 4 | |
| 17 | 2010 | 1 | |
| 18 | 2006 | 1 | |
| 19 | 2015 | 1 |
About Steve Eppler
Steve Eppler is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hepatology and Cancer Research, having authored 19 papers that have together received 956 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Melanoma and MAPK Pathways (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Treatment and Pharmacology (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Liver physiology and pathology (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Ophthalmology (129 citations), Oncology (307 citations), Radiology, Nuclear Medicine and Imaging (167 citations), Genetics (74 citations) and Hepatology (51 citations). Steve Eppler has collaborated with scholars based in United States, Switzerland and New Zealand. Frequent co-authors include Jianfeng Lü, René Bruno, Bert L. Lum, Jacques Gaudreault, William Novotny, Ashok Rakhit, Marta Hamilton, B. Lum, Lisa A. Damico‐Beyer and Tong Lu. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer Research, Clinical Pharmacology & Therapeutics and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.